Canada markets close in 4 hours 46 minutes

Orchard Therapeutics plc (ORTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.7100+0.0500 (+1.07%)
As of 11:09AM EDT. Market open.
Currency in USD

Valuation Measures

Market Cap (intraday) 5582.95M
Enterprise Value 3348.39M
Trailing P/E N/A
Forward P/E 1-4.13
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)224.64
Price/Book (mrq)1.97
Enterprise Value/Revenue 3134.26
Enterprise Value/EBITDA 7-2.57

Trading Information

Stock Price History

Beta (5Y Monthly) 1.15
52-Week Change 3-25.56%
S&P500 52-Week Change 339.21%
52 Week High 39.0800
52 Week Low 33.7600
50-Day Moving Average 35.2149
200-Day Moving Average 36.1580

Share Statistics

Avg Vol (3 month) 3459.85k
Avg Vol (10 day) 3626.6k
Shares Outstanding 5123.77M
Implied Shares Outstanding 6N/A
Float 76.52M
% Held by Insiders 10.12%
% Held by Institutions 168.86%
Shares Short (May 27, 2021) 44.62M
Short Ratio (May 27, 2021) 413.46
Short % of Float (May 27, 2021) 4N/A
Short % of Shares Outstanding (May 27, 2021) 43.73%
Shares Short (prior month Apr. 29, 2021) 44.67M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Mar. 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-5,307.63%

Management Effectiveness

Return on Assets (ttm)-23.14%
Return on Equity (ttm)-48.77%

Income Statement

Revenue (ttm)2.6M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)1.74M
EBITDA -135.72M
Net Income Avi to Common (ttm)-136.59M
Diluted EPS (ttm)-1.3200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)298.43M
Total Cash Per Share (mrq)2.41
Total Debt (mrq)53.96M
Total Debt/Equity (mrq)18.26
Current Ratio (mrq)6.77
Book Value Per Share (mrq)2.39

Cash Flow Statement

Operating Cash Flow (ttm)-115.61M
Levered Free Cash Flow (ttm)-63.13M